The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks
Open accessAbstract
The regulation of splice site usage provides a versatile mechanism for controlling gene expression and for the generation of proteome diversity, playing an essential role in many biological processes. The importance of alternative splicing is further illustrated by the increasing number of human diseases that have been attributed to mis-splicing events. Appropriate spatial and temporal generation of splicing variants demands that alternative splicing be subjected to extensive regulation, similar to transcriptional control. The Clk (Cdc2-like kinase) family has been implicated in splicing control and consists of at least four members. Through extensive screening of a chemical library, we found that a benzothiazole compound, TG003, had a potent inhibitory effect on the activity of Clk1/Sty. TG003 inhibited SF2/ASF-dependent splicing of beta-globin pre-mRNA in vitro by suppression of Clk-mediated phosphorylation. This drug also suppressed serine/arginine-rich protein phosphorylation, dissociation of nuclear speckles, and Clk1/Sty-dependent alternative splicing in mammalian cells. Consistently, administration of TG003 rescued the embryonic defects induced by excessive Clk activity in Xenopus. Thus, TG003, a novel inhibitor of Clk family will be a valuable tool to dissect the regulatory mechanisms involving serine/arginine-rich protein phosphorylation signaling pathways in vivo, and may be applicable for the therapeutic manipulation of abnormal splicing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normal Table of Xenopus Laevis (Daudin)
Nieuwkoop, P. D., & Faber, J. (1958) · Copeia · doi:10.2307/1439568 · Cited by 4,517
Normal table of Xenopus laevis (Daudin)
Gurdon, J. B. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89129-5 · Cited by 2,879
Krawczak, M., Reiss, J., & Cooper, D. (1992) · Human Genetics · doi:10.1007/bf00210743 · Cited by 1,324
Pre-mRNA splicing and human disease
Faustino, N. A., & Cooper, T. A. (2003) · Genes & Development · doi:10.1101/gad.1048803 · Cited by 1,256
Nuclear speckles: a model for nuclear organelles
Lamond, A. I., & Spector, D. L. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1172 · Cited by 1,000
SR proteins: a conserved family of pre-mRNA splicing factors.
Zahler, A. M., Lane, W. S., Stolk, J. A., & Roth, M. B. (1992) · Genes & Development · doi:10.1101/gad.6.5.837 · Cited by 798
Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2
Mayeda, A., & Krainer, A. R. (1992) · Cell · doi:10.1016/0092-8674(92)90477-t · Cited by 735
Self-citationExonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases
Blencowe, B. J. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01549-8 · Cited by 689
Lin, C.-L. G., Bristol, L. A., Jin, L., Dykes-Hoberg, M., Crawford, T., Clawson, L., & Rothstein, J. D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80997-6 · Cited by 671
Xenopus embryos regulate the nuclear localization of XMyoD.
Rupp, R. A., Snider, L., & Weintraub, H. (1994) · Genes & Development · doi:10.1101/gad.8.11.1311 · Cited by 630
Protein–protein interactions and 5'-splice-site recognition in mammalian mRNA precursors
Kohtz, J. D., Jamison, S. F., Will, C. L., Zuo, P., Lührmann, R., Garcia-Blanco, M. A., & Manley, J. L. (1994) · Nature · doi:10.1038/368119a0 · Cited by 623
Regulation of Alternative Splicing in Vivo by Overexpression of Antagonistic Splicing Factors
Cáceres, J. F., Stamm, S., Helfman, D. M., & Krainer, A. R. (1994) · Science · doi:10.1126/science.8085156 · Cited by 618
Self-citationColwill, K., Pawson, T., Andrews, B., Prasad, J., Manley, J. L., Bell, J. C., & Duncan, P. I. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00357.x · Cited by 580
Structure of the adenovirus 2 early mRNAs
Berk, A. J., & Sharp, P. A. (1978) · Cell · doi:10.1016/0092-8674(78)90252-0 · Cited by 575
Protein Diversity from Alternative Splicing
Black, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00128-8 · Cited by 564
Marshall, N. F., & Price, D. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12335 · Cited by 560
A serine kinase regulates intracellular localization of splicing factors in the cell cycle
Gui, J.-F., Lane, W. S., & Fu, X.-D. (1994) · Nature · doi:10.1038/369678a0 · Cited by 542
Modrek, B., & Lee, C. J. (2003) · Nature Genetics · doi:10.1038/ng1159 · Cited by 522
Krainer, A. R., Mayeda, A., Kozak, D., & Binns, G. (1991) · Cell · doi:10.1016/0092-8674(91)90627-b · Cited by 507
Self-citationA specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm
Cáceres, J. F., Screaton, G. R., & Krainer, A. R. (1998) · Genes & Development · doi:10.1101/gad.12.1.55 · Cited by 493
Self-citationTreatment of spinal muscular atrophy by sodium butyrate
Chang, J.-G., Hsieh-Li, H.-M., Jong, Y.-J., Wang, N. M., Tsai, C.-H., & Li, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171105098 · Cited by 404
Xiao, S. H., & Manley, J. L. (1997) · Genes & Development · doi:10.1101/gad.11.3.334 · Cited by 395
A conserved family of nuclear phosphoproteins localized to sites of polymerase II transcription.
Roth, M. B., Zahler, A. M., & Stolk, J. A. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.3.587 · Cited by 341
Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism.
Mermoud, J. E., Cohen, P. T., & Lamond, A. I. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06906.x · Cited by 330
Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I
Rossi, F., Labourier, E., Forné, T., Divita, G., Derancourt, J., Riou, J. F., Antoine, E., Cathala, G., Brunel, C., & Tazi, J. (1996) · Nature · doi:10.1038/381080a0 · Cited by 326
Correction of disease-associated exon skipping by synthetic exon-specific activators
Cartegni, L., & Krainer, A. R. (2003) · Nature Structural Biology · doi:10.1038/nsb887 · Cited by 301
Self-citationZandomeni, R., Zandomeni, M. C., Shugar, D., & Weinmann, R. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35799-x · Cited by 291
Misteli, T., Cáceres, J. F., Clement, J. Q., Krainer, A. R., Wilkinson, M. F., & Spector, D. L. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.297 · Cited by 281
Self-citationFunctional analysis of pre-mRNA splicing factor SF2/ASF structural domains.
Cáceres, J. F., & Krainer, A. R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06160.x · Cited by 257
Self-citationAndreassi, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.24.2841 · Cited by 229
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing
Sazani, P., & Kole, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19547 · Cited by 207
Gui, J. F., Tronchère, H., Chandler, S. D., & Fu, X. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10824 · Cited by 203
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing
Sazani, P., & Kole, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319547 · Cited by 198
Ben-David, Y., Letwin, K., Tannock, L., Bernstein, A., & Pawson, T. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07952.x · Cited by 194
Stamm, S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2409 · Cited by 192
In Vivo Regulation of Alternative Pre-mRNA Splicing by the Clk1 Protein Kinase
Duncan, P. I., Stojdl, D. F., Marius, R. M., & Bell, J. C. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5996 · Cited by 183
Novel SR-Protein-Specific Kinase, SRPK2, Disassembles Nuclear Speckles
Kuroyanagi, N., Onogi, H., Wakabayashi, T., & Hagiwara, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7913 · Cited by 159
Self-citationDistribution of pre-mRNA splicing factors at sites of RNA polymerase II transcription.Preprint
Neugebauer, K. M., & Roth, M. B. (1997) · Genes & Development · doi:10.1101/gad.11.9.1148 · Cited by 147
STY, a Tyrosine-Phosphorylating Enzyme with Sequence Homology to Serine/Threonine Kinases
Howell, B. W., Afar, D., Lew, J., Douville, E., Icely, P. L., Gray, D. A., & Bell, J. C. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.568-572.1991 · Cited by 142
RNA processing and human disease
Philips, A. V., & Cooper*, T. A. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000687 · Cited by 134
Pilch, B., Allemand, E., Facompré, M., et al. (2001) · PubMed · Cited by 130
Du, C., McGuffin, M. E., Dauwalder, B., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80289-0 · Cited by 118
Yun, B., Farkas, R., Lee, K., & Rabinow, L. (1994) · Genes & Development · doi:10.1101/gad.8.10.1160 · Cited by 116
Preparation of Hela Cell Nuclear and Cytosolic S100 Extracts for In Vitro Splicing
Mayeda, A., & Krainer, A. R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-676-2:309 · Cited by 112
Self-citationIdentification of Two Smad4 Proteins in Xenopus
Masuyama, N., Hanafusa, H., Kusakabe, M., Shibuyà, H., & Nishida, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.12163 · Cited by 109
Activity and Autophosphorylation of LAMMER Protein Kinases
Lee, K., Du, C., Horn, M. A., & Rabinow, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27299 · Cited by 95
Exon-specific RNAi: A tool for dissecting the functional relevance of alternative splicing
Celotto, A. M., & Graveley, B. R. (2002) · RNA · doi:10.1017/s1355838202021064 · Cited by 94
Soret, J., Gabut, M., Dupon, C., Kohlhagen, G., Stévenin, J., Pommier, Y., & Tazi, J. (2003) · PubMed · Cited by 77
AFC1, a LAMMER kinase from Arabidopsis thaliana, activates STE12-dependent processes in yeast.
Bender, J., & Fink, G. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12105 · Cited by 48
Cited by
Cooper, T. A., Wan, L., & Dreyfuss, G. (2009) · Cell · doi:10.1016/j.cell.2009.02.011 · Cited by 1,159
Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication
Karlas, A., Machuy, N., Shin, Y., Pleissner, K.-P., Artarini, A., Heuer, D., Becker, D., Khalil, H., Ogilvie, L. A., Hess, S., et al. (2010) · Nature · doi:10.1038/nature08760 · Cited by 695
Therapeutic targeting of splicing in cancer
Lee, S. C.-W., & Abdel-Wahab, O. (2016) · Nature Medicine · doi:10.1038/nm.4165 · Cited by 561
Alternative splicing in disease and therapy
Garcia-Blanco, M. A., Baraniak, A. P., & Lasda, E. L. (2004) · Nature Biotechnology · doi:10.1038/nbt964 · Cited by 527
The spliceosome as a target of novel antitumour drugs
Bonnal, S., Vigevani, L., & Valcárcel, J. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3823 · Cited by 405
Metadata
- Authors
- Muraki, M., Ohkawara, B., Hosoya, T., Onogi, H., Koizumi, J., Koizumi, T., Sumi, K., Yomoda, J.-I., Murray, M. V., Kimura, H., Furuichi, K., Shibuya, H., Krainer, A. R., Suzuki, M., & Hagiwara, M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 279
- Issue
- 23
- Pages
- 24246-24254
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2096674266
- Cited by
- 308
- References
- 49
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.